Navigation Links
Avalanche photodiodes target bioterrorism agents
Date:8/10/2008

be used to create photodiodes that require no filters because this material has an inherent response to ultraviolet, but no response to visible light or solar flux," explained Dupuis.

To improve the sensitivity at ultraviolet wavelengths, the researchers designed the gallium nitride photodiodes to operate in a mode that employs avalanche multiplication. The avalanche multiplication phenomenon is used to multiply normally tiny currents by factors of up to one million, thus dramatically increasing the device gain.

Avalanche photodiodes can create much larger currents for each photon compared to normal photodiodes. Once the necessary electric field strength has been achieved inside the device, the avalanche effect starts with just one free electron. Since the illuminated photodiode will contain many free electrons, an avalanche will always occur if the electric field is large enough.

"One electron-hole pair that is produced by a photon absorption event creates a million other electron-hole pairs and the current becomes a pulse of current that you can detect with special electronics," added Dupuis.

The researchers fabricated high-performance gallium nitride ultraviolet avalanche photodiodes on bulk gallium nitride substrates that demonstrate optical gains of 100,000 at ultraviolet wavelengths from 280 to 360 nanometers.

The gallium nitride device structures were grown by metalorganic chemical vapor deposition, a technique for depositing thin layers of atoms onto a semiconductor wafer. Many layers can be built up, each of a precisely controlled thickness and composition, to create a material which has specific optical and electrical properties. This is the first time gallium nitride was successfully used in the fabrication of photodiodes having ultraviolet optical gains greater than 10,000.

Since demonstrating the feasibility of the photodiodes to exhibit the avalanche effect, the research team has been developin
'/>"/>

Contact: Abby Vogel
avogel@gatech.edu
404-385-3364
Georgia Institute of Technology Research News
Source:Eurekalert  

Page: 1 2 3

Related biology technology :

1. Avalanche photodiodes target bioterrorism agents
2. Tiny avalanche photodiode detects single UV photons
3. Vista Partners Updates Coverage on Inovio Biomedical Corporation (Amex: INO); $3.57 Price Target
4. Epeius Biotechnologies Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteosarcoma
5. In a Year of Unprecedented Growth for Biotechnology Innovation, Targeted Therapies Gain Most Significant Traction, According to New Deloitte Study
6. Realtime Achieves ISO 13485:2003 Certification Targeting BioTech Quality Initiative
7. onTargetjobs Announces Appointment of Michael Tansey as New CEO
8. Clarification on Press Release Issued Earlier Today: Targeted Genetics Confirms Positive, Interim Phase 1/2 Study Findings
9. ASCO 2008: Tumor-Targeted Rexin-G Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Metastatic Pancreatic Cancer
10. Nektar Receives Patent Covering Pulmonary Targeted Antibiotics
11. New Study Raises Questions About Prostate Cancer Therapies Targeting Insulin-Like Growth Factor Receptor
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Avalanche photodiodes target bioterrorism agents
(Date:7/30/2015)... ATLANTA , July 30, 2015 ... leaders to the 2015 AACC Annual Meeting & ... from July 26–30. The meeting showcased revolutionary ... improves the ability of healthcare providers to diagnose ... get effective medical treatment. As ...
(Date:7/30/2015)... ... 2015 , ... The 2015 Market Research Report on the Global Propanol ... global Propanol market with a focus on the Chinese situation. Major companies included in ... ISU Chemical, Sanofi, Royal Dutch Shell, LG Chem and Zhejiang Xinhua Chemical. , The ...
(Date:7/30/2015)... KANSAS CITY, Kan. , July 30, 2015 ... PETX ), a pet therapeutics company focused on ... products for companion animals, today announced that its ... results from a dose confirmation study of AT-016, ... to Aratana for the treatment of osteoarthritis pain ...
(Date:7/30/2015)... 30, 2015 Ascendis Pharma A/S (Nasdaq: ... its innovative TransCon technology to address significant unmet ... a six-month Phase 2 study to evaluate the ... in 53 treatment-naïve, pre-pubertal children with growth hormone ... pleased with the top-line results from our Phase ...
Breaking Biology Technology:Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
... University of Pennsylvania have developed nanowires capable of ... that data a thousand times faster than existing ... micro-drives, all using less power and space than ... in the Department of Materials Science and Engineering, ...
... (Sept. 18, 2007) -- Biomedical engineers at The University ... have announced pre-clinical test results in the September issue ... of a smart particle insulin release system that detects ... insulin to counteract them. , Designed to mimic functions ...
... will bike down the California coast to ... and help those affected by arthritis, SAN FRANCISCO, Sept. ... annual Amgen California Coast Classic,Bike Tour on Saturday, September 29 ... over eight days, aim to raise more,than $1.3 million this ...
Cached Biology Technology:Penn engineers design computer memory in nanoscale form that retrieves data 1,000 times faster 2Penn engineers design computer memory in nanoscale form that retrieves data 1,000 times faster 3Smart insulin nanostructures pass feasibility test, UT study reports 2More Than 230 Cyclists to Ride in Amgen California Coast Classic Bike Tour to Raise $1.3 Million for Arthritis Foundation 2
(Date:7/30/2015)... , July 30, 2015 Cellecta, Inc., ... gene function analysis and biomarker discovery, announced the ... Knockout Library targeting all human protein coding genes. ... "knock out" a gene,s function. Cellecta,s new Human ... throughput screening tool so that researchers can investigate ...
(Date:7/23/2015)... Research and Markets ( http://www.researchandmarkets.com/research/rzzp3v/global_outlook_of ) ... Outlook of the Biometrics Industry 2015 " ... global biometrics market is likely to witness significant ... to the uptake of multiple technologies available. The ... the growth of biometrics in existing applications as ...
(Date:7/20/2015)... July 20, 2015  Acuity Market Intelligence,s latest ... Convergence of Commerce and Privacy" forecasts that between ... apps will be downloaded to smart mobile devices ... biometrics market is projected to generate more than ... the seven-year forecast period.    "Biometrics ...
Breaking Biology News(10 mins):CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2
... items of commercially available off-the-shelf equipment for combating ... Protection Equipment Demonstration (FPED VII) at Stafford Regional ... VA, during May 19-21.Uniformed and civilian members of ... responsibilities in other federal departments and agencies, state ...
... is the next frontier in biological research.As new sequencing ... available to small laboratories. Thus, sequencing data is ... However, the computing capacity needed to analyze such ... to do. Large networks of interconnected computers, called ...
... GENEVA/LAUSANNE Researchers from the Universities of Geneva and ... have been part of a major international project to ... named L1 Dominette. Sequencing the bovine genome is now ... food production, taking into account the needs of an ...
Cached Biology News:Combating Terrorism with Commercial Technology: 2009 Force Protection Equipment Demonstration 2A genomic CluE for cloud computing 2A genomic CluE for cloud computing 3Sequencing the cow's genetic code -- a new agricultural era dawns 2
Mouse monoclonal [7B9] to beta II Tubulin ( Abpromise for all tested applications). Antigen: Synthetic peptide, CEEEEGEDEA found at the c-terminus of beta II tubulin. Entrez GeneID: 10383 ...
...
... with Annexin V-FITC to distinguish cells that ... (Annexin V positive, PI negative) from those ... or already dead (Annexin V-FITC positive, PI ... range of the spectrum using a 562-588 ...
... Mouse A-20 cells were cultured in RPMI ... the log phase of growth. In order ... cells were fixed in acetone-methanol. The cells ... coated slide, with each wells surface specifically treated ...
Biology Products: